Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

276.47
+4.051.49%
Post-market: 276.43-0.0400-0.01%19:59 EDT
Volume:4.30M
Turnover:1.19B
Market Cap:488.63B
PE:78.11
High:277.60
Open:271.53
Low:270.38
Close:272.42
52wk High:277.60
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:0.73
T/O Rate:0.24%
Dividend:6.83
Dividend Rate:2.47%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-82.33
PE(LYR):117.15

Loading ...

AbbVie Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
4 hours ago

U.S. Stocks on the MOVE -VF Corp, Biogen, AbbVie

Reuters
·
7 hours ago

UBS Lifts AbbVie Target as Focus Expands Beyond Immunology Drugs

Reuters
·
Yesterday

Pharma Stocks Jump With Novavax up 12%, Moderna up 6%

Tiger Newspress
·
Yesterday

Abbvie Inc. : UBS Raises Target Price to $275 from $260

THOMSON REUTERS
·
Yesterday

AbbVie price target raised to $275 from $260 at UBS

TIPRANKS
·
Yesterday

BofA Securities Adjusts AbbVie Price Target to $305 From $289

MT Newswires Live
·
Yesterday

AbbVie price target raised to $305 from $289 at BofA

TIPRANKS
·
Yesterday

AbbVie is Maintained at Overweight by JP Morgan

Dow Jones
·
Yesterday

AbbVie Targets Jawline and Neck Aesthetics With New Botox and Juvéderm Study

TIPRANKS
·
Yesterday

AbbVie (ABBV) Lands Two FDA Breakthrough Tags For Temab A In Cancer

Simply Wall St.
·
Oct 08

Piper Sandler Sticks to Their Buy Rating for AbbVie (ABBV)

TIPRANKS
·
Oct 08

Movement Alert|AbbVie Rises 3.06% in Regular Trading, Boosted by FDA Breakthrough Therapy Designations for Cancer Drug

Market Focus
·
Oct 08

Pharma Stocks Rally With Amgen, Gilead Sciences up 3%

Tiger Newspress
·
Oct 07

Micro-Cap Stock Veraxa Biotech is Down 96% This Year. Can Next-Gen Drug Testing Save It?

Dow Jones
·
Oct 07

Morgan Stanley Adjusts Price Target on AbbVie to $310 From $296

MT Newswires Live
·
Oct 07

AbbVie’s telisotuzumab adizutecan gets two FDA Breakthrough Therapy Designations

TIPRANKS
·
Oct 07

AbbVie Says FDA Grants Breakthrough Therapy Status for ABBV-400 in Metastatic Colorectal Cancer

Reuters
·
Oct 07

Abbvie's Telisotuzumab Adizutecan (Temab-A) Receives Two Breakthrough Therapy Designations from the U.S. FDA for Crc and Nsclc

THOMSON REUTERS
·
Oct 07

Why Vaxcyte Chose A 1.5% Convertible

Macro World​
·
Oct 07